BDBM509530 3: (2R,3R,4S,5R,6R)-6-((R)-(3,4-dichlorophenyl)sulfinyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol and (2R,3R,4S,5R,6R)-6-((3,4-dichlorophenyl)sulfonyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol::US11072626, Example 2

SMILES OC[C@H]1O[C@H](Sc2ccc(Cl)c(Cl)c2)[C@H](OCC(O)=O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1

InChI Key InChIKey=RROCGPVSGSQEET-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 509530   

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM509530(US11072626, Example 2 | 3: (2R,3R,4S,5R,6R)-6-((R)...)
Affinity DataIC50: 46nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In DepthDetails
US Patent